Dr. Michael Strauss provides critical review of scientific and regulatory documentation, as well as technical writing, and methods evaluation.

Dr. Strauss’s post-graduate experience is in the development of ISO9001-certified research products. His dissertation research was on the characterization of inherent filament assembly elements within the Myosin Heavy Chain tail. Following his Ph.D., Dr. Strauss joined Eppendorf 5 Prime, the reagent arm of the German company Eppendorf AG. Dr. Strauss was initially hired to bring protein purification and fractionation expertise to Eppendorf 5 Prime, and helped develop Eppendorf’s first proteomics product, the PerfectPure C18 Desalting Tip. When research foci shifted at the company, Dr. Strauss began to lead a group that cloned, expressed and characterized numerous novel PCR enzyme systems. Finally, Dr. Strauss was promoted to manage a group producing not only novel PCR enzyme systems, but also nucleic acid purification products. His achievements as manager included finalizing the release of the Orimaster product, a product that allows users to quickly produce sequencing-grade DNA without a liquid culture step. Eppendorf 5 Prime was sold to Qiagen GmbH, to become 5 Prime, Inc. Dr. Strauss concluded his time there working on technology transfer and intellectual property documentation.

Dr. Strauss’s strengths include expertise in Molecular Biology, Protein Chemistry, Structural Biology, and Analytical Methods as well as project management and background in the biotechnology product development process.

Dr. Strauss received his B.A. from Oberlin College, his M.S. and Ph.D. from Albert Einstein College of Medicine in New York.

For a comprehensive assessment of your program requirements, please contact us by calling (720) 746-1190 or by email at info@cbrintl.com.